• Are you seeing a return to single arm studies from an HTA perspective?
• What potential drawbacks should be considered when opting for non-randomized comparative trials instead of randomized control ones?
• If a full RCT isn't feasible, what other viable approaches are available as substitutes?
• How can sponsors best communicate their research with HTAs on these alternative solutions and explain the value they present in comparison to an RTC design study?

Listen to this episode and share them with your friends and colleagues!